Abstract
Analysis of 7104 patients with melanoma seen at Duke University identified 168 who experienced their first recurrence 10 or more years after diagnosis, for an incidence of 2.4%. This included patients with all stages of disease. There was no sex, age, or primary site predominance. The mean disease-free interval for cutaneous melanomas was 14.3 years versus 22.3 years for ocular primary melanomas. The prognosis following relapse was related to the site of recurrence. Survival after local or regional node recurrence was often prolonged; survival after distant metastases was usually limited. Patients with ocular primaries had the highest incidence of distant metastases, and the shortest subsequent survival. An additional 483 patients were identified who survived 10 or more years without evidence of recurrence; of these 651 patients with long disease-free intervals, 25% (168 of 651) developed recurrent disease. This demonstrates that a 10-year disease-free interval cannot be considered a cure, and emphasizes the importance of continued annual follow-up.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Briele H. A., Beattie C. W., Ronan S. G., Chaudhuri P. K., Das Gupta T. K. Late recurrence of cutaneous melanoma. Arch Surg. 1983 Jul;118(7):800–803. doi: 10.1001/archsurg.1983.01390070012003. [DOI] [PubMed] [Google Scholar]
- Callaway M. P., Briggs J. C. The incidence of late recurrence (greater than 10 years); an analysis of 536 consecutive cases of cutaneous melanoma. Br J Plast Surg. 1989 Jan;42(1):46–49. doi: 10.1016/s0007-1226(89)90111-2. [DOI] [PubMed] [Google Scholar]
- Day C. L., Jr, Mihm M. C., Jr, Sober A. J., Harris M. N., Kopf A. W., Fitzpatrick T. B., Lew R. A., Harrist T. J., Golomb F. M., Postel A. Predictors of late deaths among patients with clinical stage I melanoma who have not had bony or visceral metastases within the first 5 years after diagnosis. J Am Acad Dermatol. 1983 Jun;8(6):864–868. doi: 10.1016/s0190-9622(83)80018-8. [DOI] [PubMed] [Google Scholar]
- Koh H. K., Sober A. J., Fitzpatrick T. B. Late recurrence (beyond ten years) of cutaneous malignant melanoma. Report of two cases and a review of the literature. JAMA. 1984 Apr 13;251(14):1859–1862. [PubMed] [Google Scholar]
- Raderman D., Giler S., Rothem A., Ben-Bassat M. Late metastases (beyond ten years) of cutaneous malignant melanoma. Literature review and case report. J Am Acad Dermatol. 1986 Aug;15(2 Pt 2):374–378. doi: 10.1016/s0190-9622(86)70182-5. [DOI] [PubMed] [Google Scholar]
- Rajpal S., Moore R., Karakousis C. P. Survival in metastatic ocular melanoma. Cancer. 1983 Jul 15;52(2):334–336. doi: 10.1002/1097-0142(19830715)52:2<334::aid-cncr2820520225>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
- Rosenkranz L., Schroeder C. Recurrent malignant melanoma following a 46-year disease-free interval. N Y State J Med. 1985 Mar;85(3):95–95. [PubMed] [Google Scholar]
- Shaw H. M., Beattie C. W., McCarthy W. H., Milton G. W. Late relapse from cutaneous stage I malignant melanoma. Arch Surg. 1985 Oct;120(10):1155–1159. doi: 10.1001/archsurg.1985.01390340053010. [DOI] [PubMed] [Google Scholar]
- Sweeney W. B., James L. P., Ghosh B. C., Vesoulis Z. Late recurrence of malignant melanoma. Am Fam Physician. 1988 Apr;37(4):243–247. [PubMed] [Google Scholar]